CDKN2A and cancer: While HPV-encoded oncogenes E6 and E7 disrupt cell cycle regulation and are key biomarkers for HPV-associated cancers [39–41], the overexpression of p16, though sensitive, is not entirely specific for high-risk HPV infection [23].